Resultados da pesquisa - Ziming Du
- A mostrar 1 - 11 resultados de 11
-
1
Upregulation of caveolin‐1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients Por Ziming Du, Chunfang Hu, Qiong Shao, Mayan Huang, Chang–Wei Kou, Xiaofeng Zhu, Yi‐Xin Zeng, Jian‐Yong Shao
Publicado em 2009Artigo -
2
Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling Por Yong Han, Zhenhua Wu, Tingfeng Wu, Yulun Huang, Zhouyang Cheng, Xiaolei Li, Ting Sun, Xiaojie Xie, Youxin Zhou, Ziming Du
Publicado em 2016Artigo -
3
-
4
Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer Por Rumana Rashid, Giorgio Gaglia, Chen Yuan, Jia‐Ren Lin, Ziming Du, Zoltan Maliga, Denis Schapiro, Clarence Yapp, Jeremy L. Muhlich, Artem Sokolov, Peter K. Sorger, Sandro Santagata
Publicado em 2019Artigo -
5
ARID1A and TERT promoter mutations in dedifferentiated meningioma Por Malak Abedalthagafi, Wenya Linda Bi, Parker Merrill, William J. Gibson, Matthew F. Rose, Ziming Du, Joshua M. Francis, Rose Du, Ian F. Dunn, Azra H. Ligon, Rameen Beroukhim, Sandro Santagata
Publicado em 2015Artigo -
6
Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma Por Shannon Coy, Rumana Rashid, Jia‐Ren Lin, Ziming Du, Andrew M. Donson, Todd C. Hankinson, Nicholas K. Foreman, Peter Manley, Mark W. Kieran, David A. Reardon, Peter K. Sorger, Sandro Santagata
Publicado em 2018Artigo -
7
Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors Por Yu Mei, Wenya Linda Bi, Noah F. Greenwald, Ziming Du, Nathalie Y.R. Agar, Ursula B. Kaiser, Whitney W. Woodmansee, David A. Reardon, Gordon J. Freeman, Peter E. Fecci, Edward R. Laws, Sandro Santagata, Gavin P. Dunn, Ian F. Dunn
Publicado em 2016Artigo -
8
Mismatch Repair Deficiency in High-Grade Meningioma: A Rare but Recurrent Event Associated With Dramatic Immune Activation and Clinical Response to PD-1 Blockade Por Ian F. Dunn, Ziming Du, Mehdi Touat, Michael B. Sisti, Patrick Y. Wen, Renato Umeton, Adrian M. Dubuc, Matthew D. Ducar, Peter Canoll, Eric A. Severson, Julia A. Elvin, Shakti Ramkissoon, Jia‐Ren Lin, Lais Cabrera, Brenda Acevedo, Peter K. Sorger, Keith L. Ligon, Sandro Santagata, David A. Reardon
Publicado em 2018Artigo -
9
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma Por Ziming Du, Malak Abedalthagafi, Ayal A. Aizer, Allison McHenry, Heather H. Sun, Mark‐Anthony Bray, Omar Viramontes, Revaz Machaidze, Priscilla K. Brastianos, David A. Reardon, Ian F. Dunn, Gordon J. Freeman, Keith L. Ligon, Anne E. Carpenter, Brian M. Alexander, Nathalie Y.R. Agar, Scott J. Rodig, Elizabeth M. Bradshaw, Sandro Santagata
Publicado em 2014Artigo -
10
Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results Por Wenya Linda Bi, Lakshmi Nayak, David M. Meredith, Joseph Driver, Ziming Du, Samantha E. Hoffman, Yvonne Li, Eudocia Q. Lee, Rameen Beroukhim, Mikael L. Rinne, Ricardo McFaline-Figueroa, Ugonma Chukwueke, Christine McCluskey, Sarah Gaffey, Andrew D. Cherniack, Jennifer Stefanik, Lisa Doherty, Christina Taubert, Meghan Cifrino, D. C. LaFrankie, Thomas Graillon, Patrick Y. Wen, Keith L. Ligon, Ossama Al‐Mefty, Raymond Y. Huang, Alona Muzikansky, E. Antonio Chiocca, Sandro Santagata, Ian F. Dunn, David A. Reardon
Publicado em 2021Artigo -
11
COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors Por Xi He, Chenshu Liu, Jiangyun Peng, Zilun Li, Fang Li, Jian Wang, Ao Hu, Meixiu Peng, Kan Huang, Dongxiao Fan, Na Li, Fuchun Zhang, Weiping Cai, Xinghua Tan, Zhong-wei Hu, Xilong Deng, Yueping Li, Xiaoneng Mo, Linghua Li, Yaling Shi, Yang Li, Yuan‐Yuan Zhu, Yanrong Wu, Huichao Liang, Baolin Liao, Wenxin Hong, Ruiying He, Jiao Jiao Li, Pengle Guo, Youguang Zhuo, Lingzhai Zhao, Fengyu Hu, Wenxue Li, Wei Zhu, Zefeng Zhang, Zeling Guo, Wei Zhang, Xiqiang Hong, Weikang Cai, Lei Gu, Ziming Du, Yang Zhang, Jin Xu, Tao Zuo, Kai Deng, Li Yan, Xinwen Chen, Sifan Chen, Chunliang Lei
Publicado em 2021Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Medicine
Biology
Cancer research
Immunology
Internal medicine
Genetics
Immune system
Immunotherapy
Antibody
Cancer
Gene
Immunofluorescence
Meningioma
Pathology
Biochemistry
Cell culture
Downregulation and upregulation
Glioma
Immune checkpoint
Immunohistochemistry
Metastasis
Nivolumab
Oncology
PD-L1
Radiation therapy
Surgery
2019-20 coronavirus outbreak
ARID1A
Adenoma
Adverse effect